ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/15 | 2,850 | 2,874 | 2,830 | 2,832 | -18 | -0.6% | 157,900 |
| 2022/06/14 | 2,840 | 2,870 | 2,836 | 2,850 | -29 | -1% | 143,700 |
| 2022/06/13 | 2,874 | 2,895 | 2,868 | 2,879 | -7 | -0.2% | 89,900 |
| 2022/06/10 | 2,901 | 2,907 | 2,883 | 2,886 | -41 | -1.4% | 164,600 |
| 2022/06/09 | 2,945 | 2,966 | 2,926 | 2,927 | -33 | -1.1% | 137,000 |
| 2022/06/08 | 2,934 | 2,976 | 2,932 | 2,960 | +34 | +1.2% | 100,700 |
| 2022/06/07 | 2,925 | 2,959 | 2,920 | 2,926 | +4 | +0.1% | 70,100 |
| 2022/06/06 | 2,920 | 2,935 | 2,910 | 2,922 | -11 | -0.4% | 90,500 |
| 2022/06/03 | 2,947 | 2,961 | 2,921 | 2,933 | -15 | -0.5% | 78,200 |
| 2022/06/02 | 2,996 | 2,998 | 2,937 | 2,948 | -52 | -1.7% | 114,300 |
| 2022/06/01 | 2,942 | 3,030 | 2,942 | 3,000 | +61 | +2.1% | 212,000 |
| 2022/05/31 | 2,940 | 2,985 | 2,935 | 2,939 | -20 | -0.7% | 218,200 |
| 2022/05/30 | 2,960 | 2,980 | 2,918 | 2,959 | +36 | +1.2% | 177,700 |
| 2022/05/27 | 2,913 | 2,940 | 2,907 | 2,923 | +16 | +0.6% | 93,400 |
| 2022/05/26 | 2,924 | 2,944 | 2,907 | 2,907 | -23 | -0.8% | 104,100 |
| 2022/05/25 | 2,979 | 2,989 | 2,930 | 2,930 | -28 | -0.9% | 97,900 |
| 2022/05/24 | 2,932 | 2,968 | 2,916 | 2,958 | +16 | +0.5% | 213,600 |
| 2022/05/23 | 2,896 | 2,958 | 2,896 | 2,942 | +60 | +2.1% | 195,700 |
| 2022/05/20 | 2,926 | 2,935 | 2,874 | 2,882 | -58 | -2% | 182,400 |
| 2022/05/19 | 2,918 | 2,971 | 2,918 | 2,940 | -38 | -1.3% | 125,100 |
| 2022/05/18 | 2,995 | 3,005 | 2,968 | 2,978 | -16 | -0.5% | 109,000 |
| 2022/05/17 | 3,020 | 3,050 | 2,991 | 2,994 | -31 | -1% | 125,100 |
| 2022/05/16 | 3,110 | 3,130 | 2,994 | 3,025 | -50 | -1.6% | 145,800 |
| 2022/05/13 | 3,085 | 3,145 | 3,065 | 3,075 | -5 | -0.2% | 132,600 |
| 2022/05/12 | 3,135 | 3,135 | 3,070 | 3,080 | -75 | -2.4% | 88,200 |
| 2022/05/11 | 3,185 | 3,185 | 3,095 | 3,155 | -100 | -3.1% | 127,600 |
| 2022/05/10 | 3,220 | 3,275 | 3,210 | 3,255 | +35 | +1.1% | 100,200 |
| 2022/05/09 | 3,235 | 3,260 | 3,205 | 3,220 | -60 | -1.8% | 90,100 |
| 2022/05/06 | 3,225 | 3,290 | 3,205 | 3,280 | +50 | +1.5% | 68,500 |
| 2022/05/02 | 3,190 | 3,245 | 3,160 | 3,230 | +35 | +1.1% | 107,800 |
| 2022/04/28 | 3,040 | 3,200 | 3,040 | 3,195 | +150 | +4.9% | 139,000 |
| 2022/04/27 | 3,090 | 3,090 | 3,035 | 3,045 | -80 | -2.6% | 120,900 |
| 2022/04/26 | 3,115 | 3,125 | 3,100 | 3,125 | +15 | +0.5% | 98,100 |
| 2022/04/25 | 3,105 | 3,135 | 3,095 | 3,110 | -45 | -1.4% | 76,400 |
| 2022/04/22 | 3,160 | 3,175 | 3,135 | 3,155 | -10 | -0.3% | 65,700 |
| 2022/04/21 | 3,160 | 3,190 | 3,145 | 3,165 | -20 | -0.6% | 88,100 |
| 2022/04/20 | 3,185 | 3,215 | 3,155 | 3,185 | +35 | +1.1% | 58,200 |
| 2022/04/19 | 3,140 | 3,175 | 3,140 | 3,150 | ±0 | ±0% | 71,900 |
| 2022/04/18 | 3,180 | 3,195 | 3,130 | 3,150 | -75 | -2.3% | 67,400 |
| 2022/04/15 | 3,200 | 3,235 | 3,200 | 3,225 | -20 | -0.6% | 55,200 |
| 2022/04/14 | 3,230 | 3,270 | 3,230 | 3,245 | +15 | +0.5% | 38,200 |
| 2022/04/13 | 3,200 | 3,245 | 3,195 | 3,230 | +20 | +0.6% | 104,700 |
| 2022/04/12 | 3,265 | 3,270 | 3,200 | 3,210 | -80 | -2.4% | 83,300 |
| 2022/04/11 | 3,255 | 3,305 | 3,255 | 3,290 | +30 | +0.9% | 69,900 |
| 2022/04/08 | 3,265 | 3,275 | 3,230 | 3,260 | +40 | +1.2% | 115,500 |
| 2022/04/07 | 3,160 | 3,230 | 3,155 | 3,220 | ±0 | ±0% | 105,900 |
| 2022/04/06 | 3,235 | 3,270 | 3,175 | 3,220 | -30 | -0.9% | 194,800 |
| 2022/04/05 | 3,270 | 3,280 | 3,235 | 3,250 | -10 | -0.3% | 72,800 |
| 2022/04/04 | 3,250 | 3,275 | 3,205 | 3,260 | +25 | +0.8% | 80,500 |
| 2022/04/01 | 3,190 | 3,255 | 3,150 | 3,235 | +35 | +1.1% | 114,800 |
601～
650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ペプチド | 273,800円 | +56.7% | +357.2% | 0.00% | 25.35倍 | 6.04倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
